Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total		Class A Common Stock	Common stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 799,269				$ 0	$ 0	$ 1,320,479	$ (553,337)	$ 7,724	$ 24,403
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2022					27,141,000	119,747,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					63,178,000	(63,178,000)
Issuance of common stock related to vested exercised stock options (in shares)						1,970,000
Issuance of common stock related to vested exercised stock options	17,603						17,603
Issuance of common stock under employee stock purchase plan (in shares)					289,000
Issuance of common stock under employee stock purchase plan	9,554						9,554
Repurchases, net of early exercised stock options (in shares)						(36,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					543,000
Vesting of early exercised stock options	4,106						4,106
Stock-based compensation expense	88,926						83,454			5,472
Change in noncontrolling interest ownership	61,726						18,153			43,573
Other comprehensive income (loss)	(16,576)								(10,598)	(5,978)
Deconsolidation of Meltano Inc.	(11,342)									(11,342)
Net loss	(138,575)							(133,578)		(4,997)
Stockholders' Equity, ending balance (in shares) at Oct. 31, 2022					91,151,000	58,503,000
Stockholders' Equity, ending balance at Oct. 31, 2022	814,691				$ 0	$ 0	1,453,349	(686,915)	(2,874)	51,131
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	830,320				$ 0	$ 0	1,413,491	(638,460)	3,456	51,833
Stockholders' Equity, beginning balance (in shares) at Jul. 31, 2022					83,025,000	65,746,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					7,810,000	(7,810,000)
Issuance of common stock related to vested exercised stock options (in shares)						584,000
Issuance of common stock related to vested exercised stock options	6,190						6,190
Repurchases, net of early exercised stock options (in shares)						(17,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					316,000
Vesting of early exercised stock options	1,146						1,146
Stock-based compensation expense	33,708						31,208			2,500
Change in noncontrolling interest ownership	4,053						1,314			2,739
Other comprehensive income (loss)	(10,261)								(6,330)	(3,931)
Net loss	(50,465)							(48,455)		(2,010)
Stockholders' Equity, ending balance (in shares) at Oct. 31, 2022					91,151,000	58,503,000
Stockholders' Equity, ending balance at Oct. 31, 2022	814,691				$ 0	$ 0	1,453,349	(686,915)	(2,874)	51,131
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	814,691				0	0	1,453,349	(686,915)	(2,874)	51,131
Stockholders' Equity, beginning balance	$ 824,725	[1]			$ 0	$ 0	1,497,373	(725,648)	(705)	53,705
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023					94,655,000	56,489,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					10,979,000	(10,979,000)
Issuance of common stock related to vested exercised stock options (in shares)	2,472,000					2,467,000
Issuance of common stock related to vested exercised stock options	$ 22,639						22,639
Issuance of common stock under employee stock purchase plan (in shares)					247,000
Issuance of common stock under employee stock purchase plan	7,751						7,751
Repurchases, net of early exercised stock options (in shares)						(13,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					1,663,000
Charitable donation of common stock (in shares)			186,899	188,000
Charitable donation of common stock	8,025		$ 8,000				8,025
Vesting of early exercised stock options	1,030						1,030
Stock-based compensation expense	120,032						122,099			(2,067)
Change in noncontrolling interest ownership							(542)			542
Other comprehensive income (loss)	(558)								2,252	(2,810)
Net loss	(390,462)							(387,707)		(2,755)
Stockholders' Equity, ending balance (in shares) at Oct. 31, 2023					107,732,000	47,964,000
Stockholders' Equity, ending balance at Oct. 31, 2023	593,182	[1]			$ 0	$ 0	1,658,375	(1,113,355)	1,547	46,615
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	831,240				$ 0	$ 0	1,610,072	(828,197)	1,782	47,583
Stockholders' Equity, beginning balance (in shares) at Jul. 31, 2023					103,432,000	51,178,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					3,621,000	(3,621,000)
Issuance of common stock related to vested exercised stock options (in shares)						407,000
Issuance of common stock related to vested exercised stock options	$ 4,706						4,706
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					625,000
Charitable donation of common stock (in shares)	54,000		53,510
Charitable donation of common stock	$ 2,675		$ 2,700				2,675
Vesting of early exercised stock options	221						221
Stock-based compensation expense	41,334						40,740			594
Change in noncontrolling interest ownership							(39)			39
Other comprehensive income (loss)	(639)								(235)	(404)
Net loss	(286,355)							(285,158)		(1,197)
Stockholders' Equity, ending balance (in shares) at Oct. 31, 2023					107,732,000	47,964,000
Stockholders' Equity, ending balance at Oct. 31, 2023	593,182	[1]			$ 0	$ 0	1,658,375	(1,113,355)	1,547	46,615
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 593,182	[1]			$ 0	$ 0	$ 1,658,375	$ (1,113,355)	$ 1,547	$ 46,615

[1] (1) As of October 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $48.6 million and $62.8 million, respectively, and liabilities of $5.9 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.